Advance in early recognition and magnetic resonance imaging diagnosis of cerebral small vessel disease

doi:10.11817/j.issn.1673-9248.2021.04.003

Abstract

Abstract:

Cerebral small vessel disease (CSVD) refers to a series of pathological syndromes resulted from the pathophysiological changes in small arteries, perforating arteries and venules. Neuropathological studies of patients with CSVD have shown that inflammation and endothelial dysfunction play a key role in it, and further research in related fields would become an important means of understanding CSVD. In recent years, with the continuous improvement of MRI scanning intensity and the clinical development of new sequences, such as arterial spin-labeled perfusion imaging and diffusion tensor imaging, clinicians are able to evaluate smaller brain structures and lesions than ever before, so that the pathological features of CSVD can be identified at an very early stage before symptoms appear.

Key words: Cerebral small vessel disease, Magnetic resonance imaging, Identified, early

Hengheng Xu, Yun Xu. Advance in early recognition and magnetic resonance imaging diagnosis of cerebral small vessel disease[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2021, 15(04): 212-217.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhnxgbzz.cma-cmc.com.cn/EN/10.11817/j.issn.1673-9248.2021.04.003

https://zhnxgbzz.cma-cmc.com.cn/EN/Y2021/V15/I04/212

References 80

1	Cannistraro R, Badi M, Eidelman B, et al. CNS small vessel disease: A clinical review [J]. Neurology, 2019, 92(24): 1146-1156.
2	顾雨铖, 徐运. 脑小血管病与血管性认知损害: 关注神经影像学 [J]. 国际脑血管病杂志, 2017, 25(3): 244-250.
3	Horsburgh K, Wardlaw JM, van Agtmael T, et al. Small vessels, dementia and chronic diseases – molecular mechanisms and pathophysiology [J]. Clini Sci (Lond), 2018, 132(8): 851-868.
4	Thrippleton M, Backes W, Sourbron S, et al. Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations [J]. Alzheimers Dement, 2019, 15(6): 840-858.
5	Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration [J]. Lancet Neurol, 2013, 12(8): 822-838.
6	Cuadrado-Godia E, Dwivedi P, Sharma S, et al. Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies [J]. J Stroke, 2018, 20(3): 302-320.
7	Noz MP, Ter Telgte A, Wiegertjes K, et al. Trained immunity characteristics are associated with progressive cerebral small vessel disease [J]. Stroke, 2018, 49(12): 2910-2917.
8	Fisher CM. Lacunes: Small, deep cerebral infarcts [J]. Neurology, 1965, 15(8): 774-774.
9	Fisher CM. Lacunar strokes and infarcts: a review [J]. Neurology, 1982, 32(8): 871-876.
10	Fisher CM. Lacunar infarcts – a Review [J]. Cerebrovasc Dis, 1991, 1(6): 311-320.
11	Caplan LR. Lacunar infarction and small vessel disease: pathology and pathophysiology [J]. J Stroke, 2015, 17(1): 2-6.
12	Yamada M. Cerebral amyloid angiopathy: emerging concepts [J]. J Stroke, 2015, 17(1): 17-30.
13	Reijmer YD, van Veluw SJ, Greenberg SM. Ischemic brain injury in cerebral amyloid angiopathy [J]. J Cereb Blood Flow Metab, 2016, 36(1): 40-54.
14	Ito J, Nozaki H, Toyoshima Y, et al. Histopathologic features of an autopsied patient with cerebral small vessel disease and a heterozygous HTRA1 mutation: CSVD with HTRA1 mutation [J]. Neuropathology, 2018, 38(4): 428-432.
15	Markus HS. Genes, endothelial function and cerebral small vessel disease in man [J]. Exp Physiol, 2008, 93(1): 121-127.
16	Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging [J]. Lancet Neurol, 2013, 12(5): 483-497.
17	Lavallée PC, Labreuche J, Faille D, et al. Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease [J]. Cerebrovasc Dis, 2013, 36(2): 131-138.
18	Rouhl RPW, JGMC Damoiseaux, Lodder J, et al. Vascular inflammation in cerebral small vessel disease [J]. Neurobiol Aging, 2011, 33(8): 1800-1806.
19	Seo SW, Kang CK, Kim SH, et al. Measurements of lenticulostriate arteries using 7T MRI: new imaging markers for subcortical vascular dementia [J]. J Neurol Sci, 2012, 322(1-2): 200-205.
20	Kang CK, Park CA, Lee H, et al. Hypertension correlates with lenticulostriate arteries visualized by 7T magnetic resonance angiography [J]. Hypertension, 2009, 54(5): 1050-1056.
21	Satoshi Y, Hiroyuki K, Ai C, et al. Evaluation of lenticulostriate arteries changes by 7 T magnetic resonance angiography in type 2 diabetes [J]. J Atheroscler Thromb, 2018, 25(10): 1067-1075.
22	Kang CK, Park CA, Lee DS, et al. Velocity measurement of microvessels using phase-contrast magnetic resonance angiography at 7 tesla MRI [J]. Magn Reson Med, 2016, 75(4): 1640-1646.
23	Dsc WLN, Beng FP, Volkau I, et al. Comparison of magnetic resonance angiography scans on 1.5, 3, and 7 Tesla units: a quantitative study of 3-dimensional cerebrovasculature [J]. J Neuroimaging, 2013, 23(1): 10.
24	Shaaban CE, Aizenstein HJ, Jorgensen DR, et al. In vivo imaging of venous side cerebral small-vessel disease in older adults: an MRI method at 7T [J]. AJNR Am J Neuroradiol, 2017, 38(10): 1923-1928.
25	Kuijf HJ, Bouvy WH, Zwanenburg JJM, et al. Quantification of deep medullary veins at 7 T brain MRI [J]. Eur Radiol, 2016, 26(10): 3412-3418.
26	Zhu XJ, Du B, Lou X, et al. Morphologic characteristics of atherosclerotic middle cerebral arteries on 3T high-resolution MRI [J]. AJNR Am J Neuroradiol, 2013, 34(9): 1717-1722.
27	Mossa-Basha M, Alexander M, Gaddikeri S, et al. Vessel wall imaging for intracranial vascular disease evaluation [J]. J Neurointerv Surg, 2016, 8(11): 1154-1159.
28	De Cocker LJL, Lindenholz A, Zwanenburg JJM, et al. Clinical vascular imaging in the brain at 7T [J]. Neuroimage, 2018, 168: 452-458.
29	Dieleman N, van der Kolk AG, van Veluw SJ, et al. Patterns of intracranial vessel wall changes in relation to ischemic infarcts [J]. Neurology, 2014, 83(15): 1316-1320.
30	Miguel MP, Knopman DS. Developmental aspects of the intracerebral microvasculature and perivascular spaces: insights into brain response to late-life diseases [J]. J Neuropathol Exp Neurol, 2011,70(12): 1060-1069.
31	Bouvy WH, Biessels GJ, Kuijf HJ, et al. Visualization of perivascular spaces and perforating arteries with 7 T magnetic resonance imaging [J]. Invest Radiol, 2014, 49(5): 307-313.
32	Bouvy WH, Zwanenburg JJ, Reinink R, et al. Perivascular spaces on 7 Tesla brain MRI are related to markers of small vessel disease but not to age or cardiovascular risk factors [J]. J Cereb Blood Flow Metab, 2016, 36(10): 1708-1717.
33	Bouvy WH, van Veluw SJ, Kuijf HJ, et al. Microbleeds colocalize with enlarged juxtacortical perivascular spaces in amnestic mild cognitive impairment and early Alzheimer’s disease: a 7 Tesla MRI study [J]. J Cereb Blood Flow Metab, 2019, 40(4): 739-746.
34	Conijn MMA, Geerlings MI, Biessels GJ, et al. Cerebral microbleeds on MR imaging: comparison between 1.5 and 7T [J]. AJNR Am J Neuroradiol, 2011, 32(6): 1043-1049.
35	Conijn MMA, Geerlings MI, Luijten PR, et al. Visualization of cerebral microbleeds with dual-echo T2*-weighted magnetic resonance imaging at 7.0 T [J]. J Magn Reson Imaging, 2010, 32(1): 52-59.
36	Bresser JD, Brundel M, Conijn MM, et al. Visual cerebral microbleed detection on 7T MR imaging: reliability and effects of image processing [J]. AJNR Am J Neuroradiol, 2012, 34(6): E61-E64.
37	Reuck DJ, Auger F, Durieux N, et al. The topography of cortical microbleeds in frontotemporal lobar degeneration: a post-mortem 7.0-tesla magnetic resonance study [J]. Folia Neuropathol, 2016, 54(2): 149-155.
38	Theysohn JM, Kraff O, Maderwald S, et al. 7 Tesla MRI of microbleeds and white matter lesions as seen in vascular dementia [J]. J Magn Reson Imaging, 2011, 33(4): 782-791.
39	Bian W, Banerjee S, Kelly DA , et al.Simultaneous imaging of radiation-induced cerebral microbleeds, arteries and veins, using a multiple gradient echo sequence at 7 Tesla [J]. J Magn Reson Imaging, 2015, 42(2): 269-279.
40	Kollia K, Maderwald S, Putzki N , et al. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T [J]. AJNR Am J Neuroradiol, 2009, 30(4): 699-702.
41	van der Land Veronica, Zwanenburg JJM, Fijnvandraat K, et al. Cerebral lesions on 7 tesla MRI in patients with sickle cell anemia [J]. Cerebrovasc Dis, 2015, 39(3-4): 181-189.
42	de Graaf WL, Kilsdonk ID, Lopez-Soriano A, et al. Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter [J]. Eur Radiol, 2013, 23(2): 528-540.
43	Tallantyre EC, Morgan PS, Dixon JE, , et al. 3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions [J]. J Magn Reson Imaging, 2010, 32(4): 971-977.
44	Nielsen AS, Kinkel RP, Tinelli E, et al. Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2 [J]. J Magn Reson Imaging, 2012, 35(3): 537-542.
45	Dury RJ, Falah Y, Gowland PA, et al. Ultra-high-field arterial spin labelling MRI for non-contrast assessment of cortical lesion perfusion in multiple sclerosis [J]. Eur Radiol, 2019, 29(4): 2027-2033.
46	Kalaria RN, Kenny RA, Ballard CG, et al. Towards defining the neuropathological substrates of vascular dementia [J]. J Neurol Sci, 2004, 226(1-2): 75-80.
47	White L, Petrovitch H, Hardman J, et al. Cerebrovascular pathology and dementia in autopsied honolulu-asia aging study participants [J]. Ann N Y Acad Sci, 2002, 977(1): 9-23.
48	Greenberg AS, Smith PEM, Schneider TAJ, et al. Cerebral microinfarcts: the invisible lesions [J]. Lancet Neurol, 2012, 11(3): 272-282.
49	Brundel M, Reijmer YD, Van Veluw SJ, et al. Cerebral microvascular lesions on high-resolution 7-Tesla MRI in patients with type 2 diabetes [J]. Diabetes, 2014, 63(10): 3523-3529.
50	Van Veluw SJ, Zwanenburg JJM, Engelen-Lee JY, et al. In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRI [J]. J Cereb Blood Flow Metab, 2013, 33(3): 322-329.
51	De Reuck JL, Deramecourt V, Auger F, et al. The significance of cortical cerebellar microbleeds and microinfarcts in neurodegenerative and cerebrovascular diseases [J]. Cerebrovasc Dis, 2015, 39(2): 138-143.
52	Benjamin P, Viessmann O, Mackinnon AD, et al. 7 Tesla MRI in cerebral small vessel disease [J]. Int J Stroke, 2015, 10(5): 659-664.
53	Sadeghi-Tarakameh A, DelaBarre L, Lagore RL, et al. In vivo human head MRI at 10.5T: a radiofrequency safety study and preliminary imaging results [J]. Magn Reson Med, 2020, 84(1): 484-496.
54	Hu H. Recent Advances of bioresponsive nano-sized contrast agents for ultra-high-field magnetic resonance imaging [J]. Front Chem, 2020, 8: 203.
55	Wang T, Hou Y, Bu B,, et al. Timely visualization of the collaterals formed during acute ischemic stroke with Fe₃O₄ Nanoparticle-based MR imaging probe [J]. Small, 2018, 14(23): e1800573.
56	Emblem KE, Mouridsen K, Bjornerud A, et al. Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy [J]. Nat Med, 2013, 19(9): 1178-1183.
57	Kłos J, van Laar PJ, Sinnige PF, et al. Quantifying effects of radiotherapy-induced microvascular injury; review of established and emerging brain MRI techniques [J]. Radiother Oncol, 2019, 140: 41-53.
58	MacDonald ME, Frayne R. Cerebrovascular MRI: a review of state-of-the-art approaches, methods and techniques [J]. NMR Biomed, 2015, 28(7): 767-791.
59	Alsop DC, Detre JA, Golay X, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia [J]. Magn Reson Med, 2015, 73(1): 102-116.
60	Telischak NA, Detre JA, Zaharchuk G. Arterial spin labeling MRI: clinical applications in the brain: arterial spin labeling MRI [J]. J Magn Reson Imaging, 2014, 41(5):1165-1180.
61	Dolui S, Li Z, Nasrallah IM, , et al. Arterial spin labeling versus 18F-FDG-PET to identify mild cognitive impairment [J]. Neuroimage Clin, 2020, 25: 102146.
62	Tang S, Liu X, He L, et al. Application of postlabeling delay time in 3-dimensional pseudocontinuous arterial spin-Labeled perfusion imaging in normal children [J]. J Comput Assist Tomogr, 2019, 43(5): 697-707.
63	Phellan R, Lindner T, Helle M, et al. A methodology for generating four-dimensional arterial spin labeling MR angiography virtual phantoms [J]. Med Image Anal, 2019, 56: 184-192.
64	Shao X, Ma SJ, Casey M, et al. Mapping water exchange across the blood–brain barrier using 3D diffusion‐prepared arterial spin labeled perfusion MRI [J]. Magn Reson Med, 2018, 81(5): 3065-3079.
65	Tiwari YV, Lu J, Shen Q, et al. Magnetic resonance imaging of blood-brain barrier permeability in ischemic stroke using diffusion-weighted arterial spin labeling in rats [J]. J Cereb Blood Flow Metab, 2017, 37(8): 2706-2715.
66	Bahrani AA, Powell DK, Yu G, et al. White matter hyperintensity associations with cerebral blood flow in elderly subjects stratified by cerebrovascular risk [J]. J Stroke Cerebrovasc Dis, 2017, 26(4): 779-786.
67	Molko N, Pappata S, Mangin JF, et al. Diffusion tensor imaging study of subcortical gray matter in CADASIL [J]. Stroke, 2001, 32(9): 2049-2054.
68	O'Sullivan M, Morris RG, Huckstep B. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis [J]. J Neurol Neurosurg Psychiatry, 2004, 75(3): 441-447.
69	Alba-Ferrara LM, de Erausquin GA. What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia [J]. Front Integr Neurosci, 2013, 7: 9.
70	Pasternak O, Sochen N, Gur Y, et al. Free water elimination and mapping from diffusion MRI [J]. Magn Reson Med, 2009, 62(3): 717-730.
71	Ji F, Pasternak O, Liu S, et al. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease [J]. Alzheimers Res Ther, 2017, 9(1): 63.
72	Cannistraro R, Badi M, Eidelman B, et al. CNS small vessel disease: A clinical review [J]. Neurology, 2019, 92(24): 1146-1156.
73	Van Opstal AM, Van Rooden S, Van Harten T, et al. Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study [J]. Lancet Neurol, 2017, 16(2): 115-122.
74	Takamura T, Hanakawa T. Clinical utility of resting-state functional connectivity magnetic resonance imaging for mood and cognitive disorders [J]. J Neural Transm (Vienna), 2017, 124(7): 821-839.
75	Brian JE. Carbon dioxide and the cerebral circulation [J]. Anesthesiology, 1998, 88(5): 1365-1386.
76	Kastrup A, Krüger G, Neumann-Haefelin T, et al. Assessment of cerebrovascular reactivity with functional magnetic resonance imaging: comparison of CO₂ and breath holding [J]. Magn Reson Imaging, 2001, 19(1): 13-20.
77	Iadecola C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease [J]. Neuron, 2017, 96(1): 17-42.
78	Thrippleton MJ, Backes WH, Sourbron S, et al. Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations [J]. Alzheimers Dement, 2019, 15(6): 840-858.
79	Heye A, Culling R, Valdés Hernández MC, et al. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review [J]. Neuroimage Clin, 2014, 6: 262-274.
80	Sourbron S, Buckley D. Classic models for dynamic contrast-enhanced MRI [J]. NMR Biomed, 2013, 26(8): 1004-1027.

[1]	Lianlian Zhang, Pinjing Hui, Yafang Ding. Clinical value of carotid Doppler ultrasonography in assessing vulnerability of atherosclerotic plaques [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 816-821.
[2]	Yanna Ye, Ruiting Ye, Yanling Chen, Wen Peng, Le Liu, Wenqiu Xiao, Hui Huang, Mingshen Li, Muyi Zhong, Xian Ye. Nomogram based on clinicopathological and imaging features to predict recurrence of benign and borderline breast phyllodes tumor [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(04): 229-237.
[3]	Xiaoyan Dong, Qi Zhao, Jun Tang, Li Zhang, Xiaoyan Yang, Jiao Li. Clinical characteristics of neonates infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 595-603.
[4]	Yu Han, Wu Zhang, Anqi Li, Wenying Chen, Sidong Xie. Diagnostic value of MRI Liver Image Reporting and Data System (LI-RADS) for hepatocellular carcinoma in patients with non-cirrhotic hepatitis B [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 669-673.
[5]	Manshi Lei, Sisi Deng, Xinrong Wang, Jinbin Huang, Qing Xiang, Anni Xiong, Zhan'ao Meng. Application of artificial intelligence-assisted compression sensing technology in upper abdominal fat-suppressed T2WI sequence [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 551-556.
[6]	Guangjun Zhong, Chunhua Liu, Wansen Zhu, Xiaolei Xu, Zhaojun Wang. Application of conventional MRI combined with different scanning sequences in preoperative staging diagnosis, chemotherapy efficacy and prognosis evaluation of gastric cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 378-382.
[7]	Baoru Hu, Naijian Shang, Di Gao. DCE-MRI and DWI findings of advanced hepatocellular carcinoma and their correlation with prognosis after immunotherapy [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 399-403.
[8]	Yuxian Wu, Yayuan Feng, Lei Huo, Ningyang Jia, Juan Zhang. Study on the diagnostic value of imaging in primary hepatic lymphoma [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(05): 349-353.
[9]	Haitao Feng, Tao Xu, Wenyang Liu, Chen Sun, Shangchao Cao. Value of three-dimensional arterial spin labeling combined with DCE-MRI in the diagnosis of postoperative recurrence and radiation brain necrosis of glioma [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(04): 262-265.
[10]	Zhiwen Wang, Xuemei Zheng, Qingkun Zhang, Haijiang Wang. Clinical analysis of 75 cases of spontaneous intracranial hypotension [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 398-401.
[11]	Meijuan Yan, Lihui Shao. Correlation between lipoprotein (a) and arteriosclerotic cerebral small vessel disease in elderly population without diabetes, hyperlipidemia and hypertension [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(05): 458-463.
[12]	Wenhua Ding, Yuwei Wang, Jingjing Qiu, Qiong Yang, Yurong Geng. Research progress on imaging biomarkers and motor dysfunction in cerebral small vessel disease [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(05): 429-434.
[13]	Daohe Wang, Yuanyuan Shi. Value of 8-iso-PGF2α and P selectin in evaluating cognitive function of patients with cerebral small vessel disease [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(04): 364-368.
[14]	Tun Zhao, Jihua Xu, Youdi He, Ming Lu. Acute spontaneous trace amount cerebral hemorrhage misdiagnosed as cerebral infarction and nearly thrombolysis: a case report [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(04): 369-372.
[15]	Lin Liu, Qishan Zhang, Manqian Liao, Yurong Chen, Bei Li, Yucheng He, Shengtao Tang. HTRA1-related autosomal dominant cerebral small vessel disease: a family report and literature review [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(04): 379-385.

Please choose a citation manager

Content to export